The origin of breast tumor heterogeneity, Oncogene, vol.34, pp.5309-5316, 2015. ,
Molecular portraits of human breast tumours, Nature, vol.406, pp.747-752, 2000. ,
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc. Natl. Acad. Sci. U. S. A, vol.98, pp.10869-10874, 2001. ,
Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion, Crit. Rev. Oncol. Hematol, vol.51, pp.55-67, 2004. ,
URL : https://hal.archives-ouvertes.fr/inserm-00144757
,
, Estrogen receptors, Pharmacol. Rev, vol.58, pp.773-781, 2006.
Steroid hormone receptors in breast cancer management, Breast Cancer Res. Treat, vol.51, pp.227-238, 1998. ,
The use of tamoxifen and raloxifene for the prevention of breast cancer, Recent Results Cancer Res. Fortschritte Krebsforsch, Progres Dans Rech. Sur Cancer, vol.181, pp.113-119, 2009. ,
Selective estrogen-receptor modulators and antihormonal resistance in breast cancer, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.25, pp.5815-5824, 2007. ,
Endocrine resistance in brea st cancer--An overview and update, Mol. Cell. Endocrinol, vol.418, issue.3, pp.220-234, 2015. ,
Biological determinants of endocrine resistance in breast cancer, Nat. Rev. Cancer, vol.9, pp.631-643, 2009. ,
Oestrogen receptor negativity in breast cancer: a cause or consequence?, Biosci. Rep, vol.36, 2016. ,
Genome -wide analysis of estrogen receptor binding sites, Nat. Genet, vol.38, pp.1289-1297, 2006. ,
ChIP-Seq of ERalpha and RNA polymerase II defines gene s differentially responding to ligands, EMBO J, vol.28, pp.1418-1428, 2009. ,
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer, Nature, vol.481, pp.389-393, 2012. ,
Pioneer factors in hormone-dependent cancers, Nat. Rev. Cancer, vol.12, pp.381-385, 2012. ,
Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists, Mod. Pathol. Off. J. U. S. Can. Acad. Pathol. Inc, vol.24, pp.157-167, 2011. ,
,
Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers, Nat. Med, vol.15, pp.907-913, 2009. ,
BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells, Cell Stem Cell, vol.7, pp.403-417, 2010. ,
Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.14, pp.2584-2589, 1996. ,
Actin dynamics control SRF activity by regulation of its coactivator MAL, Cell, vol.113, pp.329-342, 2003. ,
The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis, Genes Dev, vol.20, pp.1545-1556, 2006. ,
Requirement of a myocardin -related transcription factor for development of mammary myoepithelial cells, Mol. Cell. Biol, vol.26, pp.5797-5808, 2006. ,
Acute myeloid leukemia -associated Mkl1 (Mrtfa) is a key regulator of mammary gland function, Mol. Cell. Biol, vol.26, pp.5809-5826, 2006. ,
Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis, Nat. Cell Biol, vol.11, pp.257-268, 2009. ,
, Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer, vol.35, pp.1012-1019, 2014.
SAP domaindependent Mkl1 signaling stimulates proliferation and cell migration by induction of a distinct gene set indicative of poor prognosis in breast cancer patients, Mol. Cancer, vol.13, p.22, 2014. ,
Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk, Nat. Commun, vol.5, p.5303, 2014. ,
Activation of the MKL1/actin signaling pathway induces hormonal escape in estrogen -responsive breast cancer cell lines, Mol. Cell. Endocrinol, vol.390, pp.34-44, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01061363
The actin/MKL1 signalling pathway influences cell growth and gene expression through large -scale chromatin reorganization and histone post-translational modifications, Biochem. J, vol.461, pp.257-268, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01063933
Repression of the estrogen receptor-alpha transcriptional activity by the Rho/megakaryoblastic leukemia 1 signaling pathway, J. Biol. Chem, vol.284, pp.33729-33739, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00426655
Monolayer and aggregate cultures of rainbow trout hepatocytes: long-term and stable liver-specific expression in aggregates, J. Cell Sci, vol.105, issue.2, pp.407-416, 1993. ,
, Bioconductor: open software development for computational biology and bioinformatics, vol.5, 2004.
limmaGUI: a graphical user interface for linear modeling of microarray data, Bioinforma. Oxf. Engl, vol.20, pp.3705-3706, 2004. ,
He, clusterProfiler: an R package for comparing biological themes among gene clusters, Omics J. Integr. Biol, vol.16, pp.284-287, 2012. ,
Dynamic estrogen receptor interactomes control estrogen-responsive trefoil Factor (TFF) locus cell-specific activities, Mol. Cell. Biol, vol.34, pp.2418-2436, 2014. ,
Changes in Gene Expression and Estrogen Receptor Cistrome in Mouse Liver Upon Acute E2 Treatment, Mol. Endocrinol. Baltim. Md, vol.30, pp.709-732, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01357623
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome, Genome Biol, vol.10, 2009. ,
Genome Project Data Processing Subgroup, The Se quence Alignment/Map format and SAMtools, Bioinforma. Oxf. Engl, vol.25, pp.2078-2079, 1000. ,
Identifying ChIP -seq enrichment using MACS, Nat. Protoc, vol.7, pp.1728-1740, 2012. ,
Cistrome: an integrative platform for transcriptional regulation studies, Genome Biol, vol.12, 2011. ,
archive for high-throughput functional genomic data, Nucleic Acids Res, vol.37, pp.885-890, 2009. ,
Molecular mechanisms of epithelial -mesenchymal transition, Nat. Rev. Mol. Cell Biol, vol.15, pp.178-196, 2014. ,
Linking epithelial-to-mesenchymal-transition and epigenetic modifications, Semin. Cancer Biol, vol.22, pp.404-410, 2012. ,
The epigenetics of epithelial -mesenchymal plasticity in cancer, Nat. Med, vol.19, pp.1438-1449, 2013. ,
Repeated observation of breast tumor subtypes in independent gene expression data sets, Proc. Natl. Acad. Sci. U. S. A, vol.100, pp.8418-8423, 2003. ,
FOXA1 represses the molecular phenotype of basal breast cancer cells, Oncogene, vol.32, pp.554-563, 2013. ,
FOXC1 is a potential prognostic biomarker with functional significance in basal -like breast cancer, Cancer Res, vol.70, pp.3870-3876, 2010. ,
Profiling of estrogen up-and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype, Endocrinology, vol.144, pp.4562-4574, 2003. ,
Integrative analysis of deep sequencing data identifies estrogen receptor early response genes and links ATAD3B to poor survival in breast cancer, PLoS Comput. Biol, vol.9, 2013. ,
An oestrogen-receptor-alpha-bound human chromatin interactome, Nature, vol.462, pp.58-64, 2009. ,
GREAT improves functional interpretation of cis-regulatory regions, Nat. Biotechnol, vol.28, pp.495-501, 2010. ,
Modification of enhancer chromatin: what, how, and why?, Mol. Cell, vol.49, pp.825-837, 2013. ,
FOXC1 is enriched in the mammary luminal progenitor population, but is not necessary for mouse mammary ductal morphogenesis, Biol. Reprod, vol.89, p.10, 2013. ,
FOXC1 is involved in ER? silencing by counteracting GATA3 binding and is implicated in endocrine resistance, Oncogene, vol.35, pp.5400-5411, 2016. ,
BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal -like breast cancers, Oncogene, vol.31, pp.3667-3678, 2012. ,
Taxonomy of breast cancer based on norm al cell phenotype predicts outcome, J. Clin. Invest, vol.124, pp.859-870, 2014. ,
Amphiregulin: role in mammary gland development and breast cancer, J. Mammary Gland Biol. Neopl asia, vol.13, pp.159-169, 2008. ,
Functions of CXCL12 and CXCR4 in breast cancer, Cancer Lett, vol.238, pp.30-41, 2006. ,
Estrogen receptor mutations found in breast cancer metastases integrated with the molecular pharmacology of selective ER modulators, J. Natl. Cancer Inst, vol.107, p.75, 2015. ,
Impacts of the nuclear localization of MKL1. Fig. S2, Expression of MKL1?N200 protein in MCF7 cells induces changes in the expression of luminal-, basal-like-and HE R2-breast cancer markers ,